NeuroSense Therapeutics Ltd. Current Liabilities
NeuroSense Therapeutics Ltd. (NRSN) had Current Liabilities of $2.52 million as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-03-31
- 2025-12-31: Liabilities, Current $2.52M.
- 2025-06-30: Liabilities, Current $2.20M.
- 2024-12-31: Liabilities, Current $1.99M.
- 2024-06-30: Liabilities, Current $3.51M.
| Period end | Liabilities, Current |
|---|---|
| 2025-12-31 | $2.52M 20-F · filed 2026-03-31 |
| 2025-06-30 | $2.20M 6-K · filed 2025-08-01 |
| 2024-12-31 | $1.99M 20-F · filed 2026-03-31 |
| 2024-06-30 | $3.51M 6-K · filed 2024-09-30 |
| 2023-12-31 | $3.46M 20-F · filed 2025-04-07 |
| 2022-12-31 | $1.73M 6-K · filed 2024-06-17 |